Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jun;48(6):2321-2.
doi: 10.1128/JCM.02394-09. Epub 2010 Apr 21.

Impact of remote versus local sampling on sensitivity of genotypic antiretroviral resistance testing

Maddalena Balestrieri, Antonella Marconi, Genny Meini, Andrea Rosi, Francesco Saladini, Ilaria Vicenti, Francesca Razzolini, Maurizio Zazzi

Impact of remote versus local sampling on sensitivity of genotypic antiretroviral resistance testing

Maddalena Balestrieri et al. J Clin Microbiol. 2010 Jun.
No abstract available

PubMed Disclaimer

References

    1. Aleman, S., K. Söderbärg, U. Visco-Comandini, G. Sitbon, and A. Sönnerborg. 2002. Drug resistance at low viraemia in HIV-1-infected patients with antiretroviral combination therapy. AIDS 16:1039-1044. - PubMed
    1. Cane, P. A., S. Kaye, E. Smit, P. Tilston, S. Kirk, J. Shepherd, M. Hopkins, H. Zhang, and A. M. Geretti. 2008. Genotypic antiretroviral drug resistance testing at low viral loads in the UK. HIV Med. 9:673-676. - PubMed
    1. Hirsch, M. S., H. F. Günthard, J. M. Schapiro, F. Brun-Vézinet, B. Clotet, S. M. Hammer, V. A. Johnson, D. R. Kuritzkes, J. W. Mellors, D. Pillay, P. G. Yeni, D. M. Jacobsen, and D. D. Richman. 2008. Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society—USA panel. Clin. Infect. Dis. 47:266-285. - PubMed
    1. Peduzzi, C., P. Pierotti, G. Venturi, L. Romano, F. Mazzotta, and M. Zazzi. 2002. Performance of an in-house genotypic antiretroviral resistance assay in patients pretreated with multiple human immunodeficiency virus type 1 protease and reverse transcriptase inhibitors. J. Clin. Virol. 25:57-62. - PubMed
    1. Verhofstede, C., F. Van Wanzeele, B. Van Der Gucht, J. Pelgrom, L. Vandekerckhove, J. Plum, and D. Vogelaers. 2007. Detection of drug resistance mutations as a predictor of subsequent virological failure in patients with HIV-1 viral rebounds of less than 1,000 RNA copies/ml. J. Med. Virol. 79:1254-1260. - PubMed